Experimental obesity drug has big impact on diabetes

Researchers evaluating an experimental obesity treatment dubbed "fatostatin" said the drug not only makes mice lose weight, but it also reverses diabetes and lowers their cholesterol. Article

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.